Marshall Wace’s Audentes Therapeutics, Inc BOLD Stock Holding History

Marshall Wace’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-14,559	Closed	-$871K	–	2284
2019 Q4	$871K	Buy	14,559 +11,983	+465%	+$450K	0.01%	1020
2019 Q3	$72K	Buy	+2,576	New	+$87.9K	﹤0.01%	1433
2019 Q2	–	Sell	-90,051	Closed	-$3.51M	–	2066
2019 Q1	$3.51M	Buy	90,051 +68,937	+326%	+$1.98M	0.03%	572
2018 Q4	$450K	Buy	+21,114	New	+$545K	﹤0.01%	1144

Marshall Wace's BOLD Position: Q1 2020 in Review

Marshall Wace sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 14,559 shares — an estimated $871K sold.

Marshall Wace first reported a position in BOLD in Q4 2018 and held it in 4 quarters. The position peaked at $3.51M in Q1 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Marshall Wace reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Marshall Wace sold 14,559 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $871K.
Marshall Wace first reported a position in Audentes Therapeutics, Inc in Q4 2018 and held it in 4 quarters.
Marshall Wace's Audentes Therapeutics, Inc position peaked at $3.51M in Q1 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Marshall Wace's 13F filing for Q1 2020, filed 15 May 2020.